Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CTNM

Contineum Therapeutics (CTNM)

Contineum Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTNM
DateTimeSourceHeadlineSymbolCompany
12/16/20244:05PMBusiness WireContineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791NASDAQ:CTNMContineum Therapeutics Inc
11/27/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
11/25/20248:05AMBusiness WireContineum Therapeutics to Attend the 7th Annual Evercore HealthCONx ConferenceNASDAQ:CTNMContineum Therapeutics Inc
11/20/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
11/18/20245:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CTNMContineum Therapeutics Inc
11/18/20248:05AMBusiness WireContineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic PainNASDAQ:CTNMContineum Therapeutics Inc
11/13/20244:05PMBusiness WireContineum Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:CTNMContineum Therapeutics Inc
11/06/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
11/06/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
11/06/20244:05PMBusiness WireContineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CTNMContineum Therapeutics Inc
08/28/20244:05PMBusiness WireContineum Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:CTNMContineum Therapeutics Inc
08/14/20246:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
08/14/202412:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
08/14/202412:19PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CTNMContineum Therapeutics Inc
08/13/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
08/13/20244:05PMBusiness WireContineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CTNMContineum Therapeutics Inc
07/31/20244:05PMBusiness WireContineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple SclerosisNASDAQ:CTNMContineum Therapeutics Inc
06/24/20244:05PMBusiness WireContineum Therapeutics Announces Appointment of Sarah Boyce to Board of DirectorsNASDAQ:CTNMContineum Therapeutics Inc
06/04/20244:05PMBusiness WireContineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare ConferenceNASDAQ:CTNMContineum Therapeutics Inc
06/03/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
06/03/20245:43PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
06/03/20244:05PMBusiness WireContineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate SecretaryNASDAQ:CTNMContineum Therapeutics Inc
05/31/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
05/29/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
05/29/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
05/29/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
05/20/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
05/20/20244:05PMBusiness WireContineum Therapeutics Announces Appointment of Troy Ignelzi to Board of DirectorsNASDAQ:CTNMContineum Therapeutics Inc
05/16/20245:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
05/16/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTNM

Your Recent History

Delayed Upgrade Clock